Skip to main content
Caplight Logo









Consulta Remédios

Consulta Remédios

Private
CuritibaHealthcare & Life Scienceshttps://consultaremedios.com.br

Last Round

Corporate Funding

Jun 1, 2012

Company Overview

Consulta Remédios operates in Healthcare & Life Sciences and is based in Curitiba. Its latest recorded funding round was a Corporate Funding round in June 2012.

Consulta Remédios is a healthcare technology company that operates an online marketplace enabling consumers to search for medications, compare pharmacy prices, and access detailed pharmaceutical information.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Digital Advertising, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Marketplace Commission, Data as a Service, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Consulta Remédios Comparables

Compare Consulta Remédios with similar companies based on industry and business-model similarity.

Consulta Remédios comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Farmácias App
91%
Afya Limited
89%
ArzonApteka
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Consulta Remédios Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJun 1, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2012

    Completed a corporate funding round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Consulta Remédios Filings

Explore SEC and related filing metadata, where available.

Consulta Remédios filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Consulta Remédios's valuation, stock price, and market status.

Is Consulta Remédios a public or private company?

Consulta Remédios is a private company.

What is the current stock price of Consulta Remédios?

Consulta Remédios is a private company, so its shares have no public market price. Caplight tracks Consulta Remédios's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Consulta Remédios worth (valuation)?

Valuation information for Consulta Remédios is not publicly available.

Can I buy Consulta Remédios stock?

Consulta Remédios shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Consulta Remédios's last funding round?

Consulta Remédios's most recent funding round was Corporate Funding on June 1, 2012.

Who are the main investors in Consulta Remédios?

Investor information for Consulta Remédios is not publicly disclosed.

Will Consulta Remédios IPO soon?

No public IPO plans have been announced for Consulta Remédios.

How can I track Consulta Remédios secondary market activity?

Caplight tracks bids, offers, and trades in Consulta Remédios's shares on secondary markets.

Firmographic Details

HeadquartersCuritiba
Employee Range26
Year Founded2000
Last FundingJun 1, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?